1/ Our new paper is out: Multifaceted Effects of Antigen Valency on B Cell Responses In Vivo.
bit.ly/34MMKrJ
There is lots of excitement about nanoparticle vaccine designs, and a general consensus that multivalency is a good thing for vaccines. @ljiresearch @ImmunityCP
2/ But, mechanistic immunological understand of the impact of valency has been limited, for a variety of reasons. Here, we completed a four years study of valency and and affinity on antigen-specific B cell responses in vivo.
3/ We found that antigen valency dictates the magnitude and composition of B cell responses. Antigen valency alters breadth of B cell affinities recruited. And valency appears to modulate both the magnitude and the clonal compositions of GC responses.
4/ Under low-valency immunization, stringent affinity selection precluded most low-affinity B cell clones from participating in germinal center and plasma cell responses.
5/ In contrast, high valency immunization enabled B cell clones encompassing a broad range of affinities to efficiently participate in GCs!
6/ Valency altered the composition of the responding antigen-specific B cell population. Thus, the quantity and quality of B cell responses can be tuned by altering antigen valency, with important implications for vaccine design.
7/ Another enjoyable collaboration with the Schief lab at @scrippsresearch !
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.